Confidentiality and Non. Competition Simultaneously with the execution of this Agreement and as a condition thereto, MANAGER shall sign the Confidentiality and Non-Competition Undertaking attached as Annex A hereto. 8. Entire Agreement This Agreement constitutes the entire understanding and agreement between the parties with respect to the subject matter hereof and supersedes any and all prior discussions, arrangements, representations, understandings, agreements and correspondence and may not be amended or modified in any respect, except by a subsequent writing executed by both parties.
Confidentiality and Non. Compete -------------------------------
Confidentiality and Non disclosure Provisions--Intellectual Property and Trade Secrets. Lazarev understands and agrees that Confidential Information and Confidential Material is secret and proprietary and of great value to bCard. Lazarev further understands and agrees that the relationship between Lazarev and bCard is of a confidential nature and imposes an affirmative obligation upon Lazarev to protect, xxxxxx, and respect the confidentiality of Confidential Information. Confidential Information and Confidential Material are created, possessed, or used by Lazarev or are given to Lazarev only for the purpose of assisting Lazarev in performing his duties and services hereunder. Confidential Information and Confidential Material may be used, studied, and evaluated by Lazarev only for this purpose. Except as first authorized by bCard, Lazarev shall not directly or indirectly:
(a) disclose, reveal, report, duplicate, or transfer any Confidential Information or Confidential Material to any other person or entity; or
(b) aid, encourage, direct, or allow any other person entity to gain possession of or access to Confidential Information or Confidential Material; or
(c) copy or reproduce Confidential Material or create Confidential Material from Confidential Information; or
(d) use, sell, or exploit any Confidential Information or any Confidential Material or aid, encourage, direct, or allow any other person or entity to use, sell, or exploit any Confidential Information or Confidential Material. Upon and in accordance with bCard's instructions, Lazarev shall return or dispose of all Confidential Material. Lazarev shall, whenever requested by bCard, give a prompt and full accounting of all Confidential Material given to Lazarev and all copies or reproductions thereof. Confidential Material shall remain the property of bCard even if Lazarev is in possession thereof. In performing his duties and services hereunder, Lazarev agrees to disclose or give Confidential Information or Confidential Material to only such other persons as necessary for the performance of his duties and services hereunder or for the benefit of bCard. Any such disclosure shall be to such persons and on such terms as are consistent with bCard company policy.
Confidentiality and Non. Use All information provided to Investigator or Institution by Xxxxx, CRO or other Lilly-designated representatives, or generated by Investigator or Institution in connection with the Study, will be kept in confidence and not used for any purpose not expressly provided for in this Agreement for at least five (5) years after the termination or conclusion of the Study, except to the extent that Xxxxx gives Investigator or Institution written permission or particular information is required by laws or regulations to be disclosed to the ERB, the patient or local regulatory agencies. To the extent disclosure is requested by any other person or entity, Investigator or Institution shall promptly notify Lilly or CRO and shall not disclose any information without Xxxxx’x prior written consent. If such disclosure is sought by a third party under a claim of legal right, Investigator and Institution will reasonably cooperate with Xxxxx in the event Xxxxx wishes to take legal action to challenge such claim or the disclosure; provided, however, in no event shall Investigator or Institution be obligated to defy any law, regulation or judicial or governmental order. Investigator and Institution shall be responsible for ensuring that Investigator’s or Institution’s employees, sub-investigators, contractors and agents are obligated to these same terms of confidentiality and non-use. The terms of confidentiality and non-use set forth herein shall supersede any prior terms of confidentiality and non-use agreed to by the parties in connection with this Study. The terms of this Agreement shall also be considered confidential information and may be disclosed only to the extent required by law or necessary for approval of this Study. Additionally, in the event Investigator is invited to be an author of a Lilly publication or presentation during the course of or after the conclusion of the Study covered by this Agreement, Investigator agrees that he will hold all new information (including data from other investigator sites for Uchovávání důvěrných informací a jejich nepoužití Zdravotnické zařízení a Zkoušející se zavazují uchovávat všechny informace poskytnuté Xxxxx, CRO či jinými zástupci společnosti Lilly nebo vytvořené Zkoušejícím nebo Zdravotnickým zařízením v souvislosti se studií jako důvěrné a nepoužít je k žádnému účelu, který není stanoven touto smlouvou, a to nejméně po dobu pěti (5) let od ukončení nebo dokončení studie, pokud společnost Lilly neudělí Zkoušejícímu nebo...
Confidentiality and Non contest, or deny any such ownership rights either during or after Executive’s employment with the Company. Executive acknowledges that the Company does not voluntarily disclose Confidential Information, but rather takes precautions to prevent dissemination of Confidential Information beyond those employees such as Executive entrusted with such information. Executive further acknowledges that the Confidential Information: (a) is entrusted to Executive because of Executive’s position with the Company; and (b) is of such value and nature as to make it reasonable and necessary for Executive to protect and preserve the confidentiality and secrecy of the Confidential Information. Executive acknowledges and agrees that the Confidential Information is proprietary to and a trade secret of the Company and, as such, is a valuable, special and unique asset of the Company, the unauthorized use or disclosure of which will cause irreparable harm, substantial injury and loss of profits and goodwill to the Company. “Confidential Information” does not include any information which is generally available to and known by the public or becomes generally available to and known by the public (other than as a result of Executive’s breach of this Agreement or any other agreement or obligation to keep such information confidential).
Confidentiality and Non disclosure of information
5.1. The expert is obliged not to disclose to third persons and/or to publish any information which he obtained from the MIB for the purpose of provision of the works.
5.2. The obligation set out in art 5.1. of the agreement shall not apply to the information:
5.2.1. to disclosure and/or publishing of which the MIB granted its prior written consent;
5.2.2. disclosed to the public before execution of the agreement;
5.2.3. publicly available without any action of the expert;
5.2.4. the disclosure or publishing of which may be required by the applicable laws.
Confidentiality and Non competition
Confidentiality and Non disclosure
1. Data Processor will treat all personal data and other data received by Data Controller as confidential. Data Processor will limit the access to this data to persons working for Data Processor, who need access to correctly process the data on behalf of Data Controller.
2. All (personal) data Data Processor receives based on this Agreement are subject to a non-disclosure obligation towards third parties. All persons employed by or working for Data Processor, as well as Data Processor itself, are required to remain secrecy regarding the (personal) data.
3. Data Processor will not provide third parties with the personal data or copy, multiply or otherwise make the personal data public, without permission of Data Controller.
Confidentiality and Non. DISCLOSURE(13)
(A) CONFIDENTIALITY OF THE TERMS OF THIS AGREEMENT. The terms of this Agreement that are not otherwise required to be disclosed to the FCC in support of the De facto Transfer Application, requests for renewals thereof or notices submitted to the FCC, or as required to be disclosed in filings with the Securities and Exchange Commission or state securities agencies, will be kept strictly confidential by the Parties and their agents, which confidentiality obligation will survive the termination or expiration of this Agreement for a period of two (2) years. The Parties may make disclosures as required by law, and to employees, shareholders, agents, attorneys and accountants (collectively, "AGENTS") as required to perform obligations under the Agreement, provided, however, that the Parties will cause all Agents to honor the provisions of this section. In addition, either Party may disclose this Agreement to its Affiliates, strategic partners, actual or potential investors, lenders, acquirers, merger partners, and others whom it deems in good faith to have a need to know such information for purposes of pursuing a transaction or business relationship with it, so long as it secures an enforceable obligation from such third party to limit the use and disclosure of this Agreement as provided herein. The Parties will submit a confidentiality request to the FCC in the event the FCC seeks from the Parties a copy of this Agreement or any other confidential information regarding its terms.
Confidentiality and Non. Disparagement ------------------------------------- Executive agrees to keep the fact and terms of this Release in strict confidence. Executive agrees not to disclose this document, its contents or subject matter to any person other than his immediate family, attorney, accountant or income tax preparer, or otherwise as required by law. Executive agrees that he will not denigrate, disparage, defame, impugn, or otherwise damage or assail the reputation or integrity of the Company or any Released Party.
